Ballicules.com

Aripiprazole and Haloperidol: a Dopamine D2 receptor interaction

Aripiprazole is a partial agonist at the dopamine D2 receptor and Haloperidol an antagonist, so the two differ by how much signal is left, not by direction.

Haloperidol blocks the receptor outright. Aripiprazole binds the same site and leaves a submaximal signal behind. Swapping one for the other changes how much signal is left at the receptor, rather than reversing its direction.

Given together they work against whatever each was started for. If both are genuinely needed, expect less of Haloperidol’s effect than its dose would suggest.

This is a pharmacodynamic interaction. Neither drug changes the other’s concentration, so a level, an AUC estimate or a genotype looks entirely normal while the clinical effect is blunted.

The direction can be the useful one. The same opposition is what makes a reversal agent, an antidote or a planned antagonist work.

Aripiprazole versus Haloperidol over the Dopamine D2 receptor
Fight club: Aripiprazole versus Haloperidol — Dopamine D2 receptor

The two ballicules, with the Dopamine D2 receptor lit on each

Aripiprazole ballicule, with its Dopamine D2 receptor peg ringed
Aripiprazole (ABILIFY)
Dopamine D2 receptor partial agonist
Haloperidol ballicule, with its Dopamine D2 receptor peg ringed
Haloperidol (HALDOL)
Dopamine D2 receptor antagonist

The ring marks the peg each drug wears for this receptor — the same cross-illumination Interact! draws when the two are put side by side.

The mascots

Aripiprazole mascot mnemonic cartoon
Aripiprazole
“A ripped peep, Able to fly”
Haloperidol mascot mnemonic cartoon
Haloperidol
“Halo doll”

Open it in the console